$IBB Company News Bulls and bears vie for the SP 1,850

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
$IBB Company News

Bulls and bears vie for the S&P 1,850 resistance 11:29 a.m. Today - Michael Ashbaugh
Speculators turn the heat up to ‘soft boil’ 3:55 p.m. Jan. 16, 2014 - The Trading Deck
Juicy capital gains ahead? 6:39 p.m. Jan. 13, 2014 - Bill Donoghue
Dow industrials suffer worst drop since Sept. 20: Stock market live blog recap 4:41 p.m. Jan. 13, 2014 - blogs.marketwatch.com
Charting the early-2014 ‘pullback’ 12:33 p.m. Jan. 9, 2014 - Michael Ashbaugh
3 top trades for 2014 6:01 a.m. Dec. 30, 2013 - Jeff Reeves
Glamour stocks show resilience in Fed wake 1:35 p.m. Dec. 26, 2013 - The Trading Deck
Look out below 5:39 p.m. Dec. 23, 2013 - Bill Donoghue
S&P 500 pulls in from less-charted territory 11:17 a.m. Dec. 11, 2013 - Michael Ashbaugh
Stay the course with caution 4:04 p.m. Dec. 2, 2013 - Bill Donoghue
This backdrop is what bull markets are made of 1:58 p.m. Dec. 2, 2013 - The Trading Deck
Nasdaq Composite rattles cage on the 4,000 mark 11:29 a.m. Nov. 25, 2013 - Michael Ashbaugh
From tiny Akorns grow mighty oaks? 10:03 a.m. Nov. 21, 2013 - The Trading Deck
The best stock sector for your money now 6:01 a.m. Nov. 15, 2013 - Howard Gold
ETFs to ride the market’s peaks 11:01 p.m. Nov. 3, 2013 - Jim Lowell
Top performers’ top November bets 11:01 p.m. Nov. 3, 2013 - Mark Hulbert
Don’t let taxes eat up your portfolio 4:31 p.m. Oct. 28, 2013 - Bill Donoghue
Healthcare stocks fall from first place in race for year's best-performing sector 2:32 p.m. Oct. 24, 2013 - blogs.marketwatch.com
Gold miners, biotech among worst-performing ETFs during shutdown 3:01 p.m. Oct. 15, 2013 - blogs.marketwatch.com
Here’s what happens when institutions blink 10:41 a.m. Oct. 11, 2013 - The Trading Deck


Biotech Hazard: Is It Different This Time? 10:52 a.m. Today - Seeking Alpha
Biotech Is on Fire 6:00 p.m. Jan. 21, 2014 - RealMoney.com
Google's Newest Venture: Smart Contact Lenses 2:19 p.m. Jan. 21, 2014 - Seeking Alpha
Intercept Pharma (ICPT) Pushes SPDR Biotech ETF Ahead of Rivals - ETF News And Commentary 7:54 a.m. Jan. 10, 2014 - Zacks.com
2014 Biotechnology Catalysts 4:18 p.m. Jan. 9, 2014 - Seeking Alpha
Biotech Bull Market: 2014 Key Trends To Watch 1:43 p.m. Jan. 9, 2014 - Seeking Alpha
Intercept shares go crazy, Galectin jumps 10:05 a.m. Jan. 9, 2014 - Seeking Alpha
Sector ETFs Breaking Out (IBB, IHE, XLV, IAT, SKYY) 3:27 p.m. Jan. 8, 2014 - Benzinga.com
Is the Biotech Boom Over? 10:58 a.m. Jan. 7, 2014 - Barrons.com
Interesting IBB Put And Call Options For February 22nd 10:45 a.m. Jan. 7, 2014 - TheStreet.com
Exelixis Has A Stellar Year Ahead 5:21 p.m. Jan. 6, 2014 - Seeking Alpha
GILD: Get on While Biotech Remains Hot 5:15 a.m. Jan. 3, 2014 - InvestorPlace.com
Why You Should Sell 3D Systems And Buy Organovo 4:20 p.m. Dec. 30, 2013 - Seeking Alpha
Market Not Overbought Despite Big Gains 8:43 p.m. Dec. 22, 2013 - InvestorPlace.com
Investigating Micro-Cap Medtech With Explosive Upside Potential: Brian Marckx 11:03 a.m. Dec. 21, 2013 - Seeking Alpha
'Fast Money' Recap: A Relief Rally 5:00 a.m. Dec. 19, 2013 - TheStreet.com
Arno Therapeutics: A Likely Acquisition For Opko 1:54 p.m. Dec. 17, 2013 - Seeking Alpha
The Race To Treat Stage III Melanoma Just Got A Lot More Interesting 1:46 p.m. Dec. 17, 2013 - Seeking Alpha
OPK – With Opko Health Hammered, Should You Run or Buy? 4:45 a.m. Dec. 17, 2013 - InvestorPlace.com
Why Northwest Biotherapeutics Is Different 3:21 p.m. Dec. 16, 2013 - Seeking Alpha


Regulus Announces Addition to NASDAQ Biotechnology Index 8:00 a.m. Dec. 23, 2013 - PR Newswire
Epizyme, Inc. to Be Added to NASDAQ Biotechnology Index (NBI) and NASDAQ Global Select Market 8:00 a.m. Dec. 20, 2013 - PR Newswire
KYTHERA Biopharmaceuticals Announces Addition to the NASDAQ Biotechnology Index 5:51 p.m. Dec. 19, 2013 - GlobeNewswire
Verastem Announces Addition to the NASDAQ Biotechnology Index 7:00 a.m. Dec. 19, 2013 - BusinessWire
Horizon Pharma to Be Added to NASDAQ Biotechnology Index 7:30 a.m. Dec. 17, 2013 - Marketwire
Chimerix Added to NASDAQ Biotechnology Index (NBI) 7:00 a.m. Dec. 17, 2013 - GlobeNewswire
Annual Changes to the NASDAQ Biotechnology Index 8:05 a.m. Dec. 16, 2013 - GlobeNewswire
Galectin Stands Out in 2013 with Liver Fibrosis Drug 11:06 a.m. Oct. 14, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on ARRY, GNVC, IDIX and NVAX 8:02 a.m. Sept. 16, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on ARIA, ARNA, EXEL and OREX 8:05 a.m. Sept. 11, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on CYTX, GALT, IMMU and OXBT 7:52 a.m. Sept. 11, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on ACHN, BLRX, DSCO and ONCY 7:51 a.m. Sept. 10, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on ACAD, CUR, INO and PIP 7:41 a.m. Sept. 10, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on DNDN, HALO, MNKD and PDLI 7:30 a.m. Sept. 10, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on GILD, ITMN, MDVN and PBYI 8:01 a.m. Sept. 6, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on ALXN, AMGN, CBST and CLDX 7:50 a.m. Sept. 6, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on BIIB, CYTK, ISIS and SRPT 7:40 a.m. Sept. 6, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on ANAC, RPRX, THLD and THRX 7:52 a.m. July 17, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on CYTK, DNDN, IMGN and NVAX 7:43 a.m. July 17, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on ACAD, CELG, SIGA and SNTS 7:31 a.m. July 17, 2013 - ACCESSWIRE

Scroll down for more posts ▼

Top 10 Most Recent News Articles

El Pollo Loco Faces Class Action Over Wage Practices

Updated Category News Views 483

Alright, here's where things start sizzling—El Pollo Loco, the fast-food chicken chain whose name translates to 'The Crazy Chicken'—is in a legal pickle. The lawsuit hanging over their heads could spell a sticky situation for them and possibly ripple through the fast-food industry. The suit, filed by the steadfast firm Blumenthal Nordrehaug Bhowmik De Blouw LLP, has...

Continue Reading
Luvme Hair Offers Wig Variety for Winter Fashion

Updated Category News Views 371

Adding Flair to Winter Looks A style kick-off from the fashion world: Luvme Hair is flipping the table on winter wardrobes with a new collection of wigs. As the weather ramps up the need for thick coats and cumbersome layers, these long hairstyles offer a little extra swing, bringing dimension into the mix. Fancy a change from traditional winter hibernation? Here’s what...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 152

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
EFICYENT Ventures to Connect at Singapore FinTech Fest

Updated Category News Views 280

Why the Singapore FinTech Festival Matters The world's hardly a stranger to hype, but the Singapore FinTech Festival carries some real weight. From November 18 to 20, 2026, this gig isn't just industry chatter—it's a high-stakes convergence of policymakers, financial institutions, fintech innovators like EFICYENT, and the money folk looking to mold the future of...

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 445

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
Breakthrough T1D Pushes Global T1D Awareness Forward

Updated Category News Views 292

Shining a Light on T1D with Global Efforts In a world where a change in lifestyle can happen at the drop of a hat, Breakthrough T1D is making waves by expanding their global "See T1D" campaign in honor of World Diabetes Day. This isn't your run-of-the-mill awareness push—this is about propelling an understanding of what life truly entails for those living with type 1...

Continue Reading
Retirement Dreams Dashed: 61% Withdraw Early

Updated Category News Views 382

Retirement Caught in the Crosshairs Just when you think the path to retirement might clear up, life slaps down older workers with economic reality. A recent LiveCareer survey underscores this financial mess, revealing that 61% of those 50 and older are raiding their own retirement funds to make ends meet. It's enough to make one's head spin. Inflation: The Unwanted Guest...

Continue Reading
YSTUDIO's Pens: A Nod to the Power of Writing

Updated Category News Views 487

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Continue Reading
Fluence Energy Faces Leadership Departures Amid Legal Woes

Updated Category News Views 279

Fluence Energy's Rocky Road Continues It's chaos once again in the halls of Fluence Energy (NASDAQ:FLNC). The ship seems to drift further from solid ground as their CEO and CFO candidly decided to jump ship, shaking investor confidence even more vigorously. The market's reaction was swift and brutal: a nasty 9% share drop, leaving investors with more than just a headache....

Continue Reading
HONGQI's EHS4 Launch in Europe: Bridging East and West

Updated Category News Views 222

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

Continue Reading

Top 5 Most Recently Viewed Articles

Insights on Stocks: Applied Materials, Coupang, and Starbucks

Updated Category News Views 176

Market Highlights from CNBC's Final Trades In the latest episode of CNBC's “Halftime Report Final Trades,” Jim Lebenthal from Cerity Partners highlighted a compelling trade with Applied Materials, Inc. (NASDAQ: AMAT), suggesting it's one to watch closely in the current market environment. Applied Materials: Recent Developments Recently, applied materials found itself...

Continue Reading
Investors Urged to Take Action on Biohaven Ltd. Lawsuit

Updated Category News Views 101

Key Details for Biohaven Ltd. Investors Attention investors! If you've acquired securities of Biohaven Ltd. between certain dates, it's crucial to know about an ongoing class action lawsuit that may affect you. Now is the time to ensure your rights are protected. Why You Should Act Now The Rosen Law Firm has announced an important deadline for those who purchased Biohaven...

Continue Reading
ProPhase Labs Inc. Growth Update: Strategies & Innovations

Updated Category News Views 141

ProPhase Labs Inc. Update Overview Diamond Equity Research has recently published a significant update on ProPhase Labs Inc. (NASDAQ: PRPH), shedding light on the company’s strategic initiatives and innovations. This analysis explores ProPhase's evolving business model, its position within the industry, financial performance, and potential market risks. Growth...

Continue Reading
Donaldson Company Reports Record Sales and Ambitious 2026 Goals

Updated Category News Views 216

Donaldson Company Reports Outstanding Results for Fourth Quarter Donaldson Company (NYSE: DCI) has recently provided an impressive overview of its fourth-quarter and full-year fiscal 2025 performance. The company reported remarkable sales figures and notable earnings that reflect its ability to navigate market challenges effectively. With guidance for fiscal 2026 now in...

Continue Reading
Brandywine Realty Trust's 2024 Financial Performance Revealed

Updated Category News Views 189

Brandywine Realty Trust Reports Impressive Results for 2024 In a recent announcement, Brandywine Realty Trust (NYSE: BDN) showcased its financial and operational results for 2024, indicating strong performance across several metrics. As the company evaluates these results, it prepares for an even more promising outlook in 2025. Remarkable Achievements in 2024 Operational...

Continue Reading